Back Refine search Reset
Please choose a search criteria from below
Filters Clear all
Specialties
Treatments

100+ results found in London, UK

Sort by:
Showing 31 - 40 of 100+ results
Expert in: Oncology
24 years of experience

Dr Ananth Shankar is a Consultant Paediatric and Adolescent Oncologist. He is based at University College London Hospitals NHS Trust and is the Clinical Lead for Adolescent Neuro-oncology. He is an Honorary Senior lecturer in Paediatrics at the ICH/UCL and is a Fellow of the Royal College of Paediatrics and Child Health. He specialises in adolescent neuro-oncology and nodular Lymphocyte Predominant Hodgkin’s Lymphoma [LPHL]

After graduating in medicine from Cailcut Medical College in India, he trained in Paediatric Oncology at Our Lady’s Hospital for Sick Children in Dublin and the Royal Marsden Hospital. He completed a Research Fellowship at Queen Mary and Westfield College in London, with his thesis investigating Paediatric Lymphomas.

Dr Shankar is actively involved in research into Lymphocyte Predominant Hodgkin’s Lymphoma and is the current UK Chief Investigator for the International EuroNet LPHL trial. He is an undergraduate examiner with University College London and is also a clinical and educational supervisor of paediatric oncology trainees.


Diseases, Medical Tests and Treatments
  • Chemotherapy
  • Intraventricular Chemotherapy

 

 

  • Hodgkin Lymphoma 
  • Leukaemia 
  • Lymphoma 
  • Melanoma 
  • Myeloma 
  • Neuro-endocrine Tumours (NETs) 
  • Nodular Lymphocyte Predominant Hodgkin's

 

Read more
Dr Riyaz Shah

Dr Riyaz Shah

1.25 miles

Dr Riyaz Shah

1.25 miles
Expert in: Oncology
25 years of experience
Clinical Oncology, Medical Oncology

Dr Riyaz Shah is a Consultant Medical Oncologist at The Harley Street Clinic and Maidstone and Tunbridge Wells NHS Trust. He specialises in lung and gastrointestinal cancers and malignant mesothelioma.

Dr Shah completed his medical degree at the University of London and obtained a First Class Honours Intercalated BSc in Experimental Pathology. Following this he undertook further medical training at The London Chest Hospital, Hammersmith Hospital, University College London, Guy’s Hospital and The Royal Marsden. In 1997 he became a member of the Royal College of Physicians of London. He undertook a Clinical Research Fellowship with The Imperial Cancer Research Fund to investigate abnormal genes in pancreatic cancer. This work led to him being awarded with a PhD by Imperial College London. Following this, Dr Shah trained to become a specialist in Medical Oncology at The Royal Marsden Hospital and was awarded an ASCO Foundation Merit Award. In 2006 he was appointed Consultant Medical Oncologist at the Kent Oncology Centre.

Dr. Shah is actively involved in training future medical oncologists and has an extensive role in clinical research. He has been a principal investigator on many trials at his centre and has been instrumental in the introduction of immunotherapy into routine clinical practice within Kent. He has served on the NCRI Lung Group, acted as chairman of the Kent Lung Network Lead and continues to be the lead for research at his Cancer Centre. He has been published widely and is regularly asked to speak both nationally and internationally on cancer issues.


Diseases, Medical Tests and Treatments
  • Chemotherapy 
  • Immunotherapy 
  • Cancer of Unknown Primary 
  • Colorectal Cancer 
  • Gastro-intestinal Cancers 
  • Lung Cancer 
  • Thoracic Cancer
  • Acute Oncology
Read more
Dr Sherif Raouf

Dr Sherif Raouf

1.25 miles

Dr Sherif Raouf

1.25 miles
Expert in: Oncology
21 years of experience
Clinical Oncology

Dr Sherif Raouf is a cancer specialist (Consultant Clinical Oncologist) at St Bartholomew's Hospital. After having graduated in 1986, he completed his oncology training at Charing Cross, Mount Vernon and University College London Hospitals. Following that, he took up his current role at Queens Hospital, where since 2005 he has been the lead clinician in colorectal cancers and a key part of the GI team involved in managing up to 350 cancer patients a year.

Dr Raouf is also very experienced in the use of targeted therapies in the treatment of cancers and has pushed for the use of cutting edge technology. One such state of the art radiotherapy machine is called RapidArc (VMAT) which was potentially revolutionary many years ago as it more accurately targets the tumour, reducing the damage to surrounding tissues. Such targeted therapy has been shown to reduce side effects and improve prognoses.

On the research side, Dr Raouf is interested in cancer epidemiology and chemo-radiotherapy in cancer management. Furthermore, he is known globally for his role as a guest lecturer at many conferences worldwide. Consequently, he is currently a Fellow of the Royal College of Radiologists, a member of the European Society for Therapeutic Radiology and Oncology, The American Society of Radiation Oncology and The American Society of Clinical Oncology. Dr Raouf is hence clearly a figure at the top of his field, who is respected by all his peers.


Diseases, Medical Tests and Treatments
  • Biological Therapy
  • Cancer Prevention And Screening
  • Chemotherapy
  • Immunotherapy
  • Neoadjuvant
  • Radiotherapy
  • Targeted Chemo-Radiation Therapy
  • Stereotactic Radiosurgery
  • Adenocarcinoma
  • Bilary Cancer
  • Bowel Cancer
  • Cancer Of Unknown Primary
  • Cervical Cancer
  • Colorectal Cancer
  • Gastro-Intestinal Cancers
  • Gynaecological Cancers
  • Laryngeal Cancer
  • Liver Cancer
  • Lung Cancer
  • Nasal & Sinus Cancer
  • Nasopharyngeal Cancer
  • Neuro-Endocrine Tumours (NETs)
  • Oesophageal Cancer
  • Oral (Mouth) Cancer
  • Ovarian Cancer
  • Palliative Care
  • Pancreatic Cancer
  • Penile Cancer
  • Prostate Cancer
  • Salivary Gland Cancer
  • Stomach Cancer
  • Throat Cancer
  • Urological Cancers
Read more
Dr Stephen Karp

Dr Stephen Karp

1.25 miles

Dr Stephen Karp

1.25 miles
Expert in: Oncology
40 years of experience
Clinical Oncology

Dr Stephen Karp is a Consultant Clinical Oncologist at North Middlesex Hospital. His preclinical studies were at King’s College London where he also obtained an intercalated BSc in Pharmacology (1st Class Honours). He graduated in Medicine from Westminster Hospital Medical School in 1979 with a distinction in Surgery. His postgraduate training included cardiology at Hammersmith Hospital and neurology at the National Hospital Queen Square as well as general medicine at Whittington Hospital. He was a gastroenterology registrar at Northwick Park Hospital and trained in clinical oncology at the Middlesex Hospital and Mount Vernon Hospital.

Although Dr Karp was trained and initially practised in almost all areas of oncology, he is now specialized in treating cancers of the breast, GI tract (colorectal, oesophagogastric, pancreatic) and urological cancer (prostate and bladder cancer) with chemotherapy, hormone therapy, biological therapy and radiotherapy, including Cyberknife and SABR.


Diseases, Medical Tests and Treatments
  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
  • IMRT IGRT
  • SABR
  • Cyberknife
  • Chemotherapy
  • Hormone therapy
  • Immunotherapy
  • Biological therapy
  • Breast, gastrointestinal and prostate cancer (chemotherapy and radiotherapy)
Read more
Expert in: Oncology
28 years of experience
Clinical Oncology

Dr Teresa Guerrero Urbano is a Consultant Clinical Oncologist and clinical lead for Radiotherapy at Guy’s and St Thomas’ NHS Foundation Trust and King’s College, London. She is honorary Senior Lecturer at the University of Surrey. Her areas of expertise include: Head & Neck Cancer, Non melanomatous skin cancer and Prostate cancer. Dr Guerrero Urbano has previously held senior Consultant Clinical Oncologist and Honorary Senior Lecturer positions at Royal Surrey County NHS Trust, Basingstoke and North Hampshire NHS Foundation Trust, University of Surrey. She was a Senior Research Fellow at University College London and a Clinical Cancer Research Fellow at the Institute of Cancer Research and Royal Marsden Hospital.

Dr Guerrero Urbano completed her oncology training at the Royal Marsden, Royal Surrey County and Guy’s and St Thomas’ Hospitals. She completed her PhD at the University of London in 2008. Dr Guerrero Urbano is joint Module Leader for the Respiratory, Head and Neck module, MSc in Oncology, Institute of Cancer Research. She offers weekly Oncology Seminars at St Luke’s Cancer Centre aimed at doctors, nurses, radiographers and physicists and monthly lectures at the post-graduate Medical School at the University of Surrey. She is a PhD and MD examiner. Her formal research evaluated technical and biological aspects of intensity-modulated radiotherapy at the Institute of Cancer Research/Royal Marsden Hospital. Dr Guerrero Urbano is particularly interested in the use of novel radiation techniques to minimize long-term side effects and the use of chemotherapy and targeted therapy to improve outcomes. Dr Guerrero Urbano has published her research widely and spoken at conferences worldwide.


Diseases, Medical Tests and Treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
  • Head and neck cancer
  • Technical and biological aspects of image-guided radiotherapy (IGRT)
  • Intensity-modulated radiotherapy (IMRT)
  • Cancer imaging applied to radiotherapy treatments
Read more
Expert in: Oncology
33 years of experience
Clinical Oncology

Dr Stephanie Gibbs graduated from the Royal Free Hospital Medical School in 1986. She trained in Oncology at the Middlesex Hospital, Mount Vernon Hospital, The Royal London Hospital and St Bartholomew's Hospital. She took up a consultant post at BHR Hospitals NHS Trust in 1998 & worked there for over 21 years. 

She specialises in the treatment of urological and breast cancers using radiotherapy and drug therapies including hormone teatments, chemotherapy, targeted therapies and radioisotope treatment. She is trained in the use of advanced radiotherapy techniques including IMRT, IGRT, the use of SpaceOAR Hydrogel for prostate radiotherapy and SABR.

My hobbies are keeping fit, theatre, and dance.


Diseases, Medical Tests and Treatments
  • Urological cancer
  • Breast cancer
  • Chemotherapy
  • Radiotherapy
  • Urological cancers
  • Chemotherapy
  • Radiotherapy
Read more
Dr Peter Harper

Dr Peter Harper

1.25 miles

Dr Peter Harper

1.25 miles
Expert in: Oncology
49 years of experience

Dr Peter Harper trained at University College and University College Hospital (MB BS 1970) and has been a leading consultant at Guy's and St Thomas Hospital for over 25 years. He is both an accredited physician and a medical oncologist. One of the four founder partners of the London Oncology Clinic, his vision was of a clinic dedicated solely to cancer treatment offering the highest international standards of care in a state-of-the-art supportive environment, also providing the support including all the ancillary care required by patients and their families.

Author of more than 400 papers and chapters in peer-reviewed publications, he is acknowledged globally for his work in researching new drugs and developing improved forms of cancer treatment. He has been the chair, or has been a member of many international executive committees investigating new approaches to cancer treatment, editorial boards for professional publications and is currently a member of eight pharmaceutical company advisory boards and is a member of sixteen professional bodies from around the world, including board membership of a committee of the American Society of Clinical Oncologists (ASCO).

In 2002 he was awarded the prestigious Cino del Duca Medal in 2004 in recognition of his work in developing new anti-cancer and vaccine therapies. For his role in advising the French Government in strategic cancer care (Board Member French National Cancer Institute), he was appointed a Chevalier of the Legion D'Honneur, a rare distinction for a foreign national. He remains on the board of INCA, the strategic committee for cancer treatment in France, and is currently the Chairman of the Toulouse Cancer Centre and holds the Medaille D'Or of that city.


Diseases, Medical Tests and Treatments
  • Chemotherapy of solid tumours
  • Gynaecological cancers
  • Gastrointestinal cancers
  • Breast cancer
  • Lung cancer
  • Urological cancers
  • Chemotherapy of solid tumours
  • Gynaecological cancers
  • Gastrointestinal cancers
  • Breast cancer
  • Lung cancer
  • Urological cancers
Read more
Expert in: Oncology
20 years of experience
Medical Oncology

I am a Medical Oncology Consultant for the Gastrointestinal Oncology Service at University College London Hospitals NHS Foundation Trust and Honorary Associate Professor at the UCL Cancer Insitute. I treat oesophageal, stomach, small bowel, colorectal and hepatobiliary cancers, as well as cancers of unknown primary. I am the UCLH Clinical Lead for the Cancer of Unknown Primary (CUP) Service and the Acute Oncology Service.


My research interests include immunotherapy for GI malignancies and Cancer of Unknown Primary, with focus on clinical trials and translational research of these cancers. I am Chief Investigator or Principal Investigator for a number of  GI or CUP immuno-oncology Phase 2 and 3 trials, including KEYNOTE 177, KEYNOTE 859, KEYNOTE 811, KEYNOTE 975,  VESTIGE, POLEM and CUPISCO.


I am Chair of the NCRI MUO-CUP Workstream as part of the Living With and Beyond Cancer CSG, and a member of the NCRI Colorectal Advanced and Adjuvant Disease Subgroup. I am the Principal Investigator of the UCL-UCLH GI + CUP Cancer Translational Research Biobank and a collaborator with the GI Oncology and CUP subgroups at the UCL Cancer Institute and Francis Crick Institute. I am a member of ASCO, ESMO and the Association of Cancer Physicans (UK).


I strongly believe in clinicians being educators and enjoy teaching oncology to UCL medical students, oncology and non-oncology junior trainees. I also give talks nationally and abroad at conferences and other hospitals to share best practice and future perspectives in the fields of GI oncology research, CUP, immunotherapy and novel trial designs.


To make an appointment or enquiry please contact my secretary Alanna Sarwar on asarwar@theloc.com or +44207 317 2659.


Diseases, Medical Tests and Treatments
  • Gastrointestinal Oncology - oesophageal, stomach, hepatobiliary and bowel cancers
  • Cancer of Unknown Primary
  • Acute Oncology
  • Chemotherapy
  • Targeted therapy
  • Immunotherapy
  • Clinical Trials
  • Immunotherapy
  • Gastrointestinal Oncology Research 
  • Cancer of Unknown Primary Research 
  • Molecular Profiling with solid and liquid biopsies
  • Biomarker Driven Clinical Trial Design and Implementation
Read more
Expert in: Oncology
36 years of experience

Professor Daniel Hochhauser is a specialist in the treatment of gastrointestinal cancer, conducting research which focuses on the development of novel therapeutics.

 

 

Professor Hochhauser qualified in medicine from Cambridge and the Royal Free Hospital Medical School. Following postgraduate training, he was appointed Clinical Fellow in Medical Oncology at the Institute of Molecular Medicine, Oxford where he completed a DPhil, subsequently training at Memorial Sloan Kettering Cancer Center New York before appointment as a consultant in 1996. 


Diseases, Medical Tests and Treatments
  • Home chemotherapy

 

  • Gastrointestinal cancers (chemotherapy)
  • Upper gastrointestinal cancers
  • Lower gastrointestinal cancers
Read more
Expert in: Oncology
45 years of experience
Clinical Oncology

Dr Ronald Beaney did his undergraduate training in Scotland followed by posts abroad and in the UK. His oncology training was at the Hammersmith Hospital in London where his MD thesis was on the role of positron emission tomography in oncology. He has been a Consultant Clinical Oncologist attached to Guy's and St Thomas and Kings College Hospitals in London. He has produced more than 100 publications on a range of oncological topics.

Dr Beaney's major clinical interests lie in tumours of the brain (gliomas) and pelvis (prostate and gynaecological tumours). He is a member of several UK, European and American Cancer Societies and examiner for the Royal College of Radiologists.


Diseases, Medical Tests and Treatments

Cyberknife

Gammaknife

  • Clinical oncology 
  • Gynae
  • Prostate
  • Bladder
  • Central nervous system tumours
  • Testicular Cancer
  • Renal Cancer
  • Ovarian Cancer
  • Neuroendocrine Tumours (NETs)
Read more